On 15 November 2016, the European Commission (“the Commission”) opened its second report on Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12...08 December 2016
HHS OIG Releases Proposed Rule Regarding Exclusion from Federal Health Care Programs
The proposed rule codifies the OIG’s authority to impose permissive exclusion for:
- Convictions relating to obstruction of an investigation or audit;
- Failure to provide payment information, including by individuals who “order, refer for furnishing, or certify the need for” items or services paid for by Medicare or State health care programs; and
- Making false statements or misrepresenting materials facts in applications to participate as a provider or supplier under a Federal health care program.
Other proposed changes include proposing early reinstatement rules for individuals excluded as a result of losing their licenses, the mandatory exclusion waiver provision, amendments of mitigating and aggravating factors, and other administrative process changes.
Hogan Lovells is currently analyzing the proposed rule and is happy to provide additional information upon request.
Comments to the proposed rules must be received to OIG by 5 PM EST on July 8, 2014.
On 26 September 2016, a new EU-US collaboration between the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) was announced. This new collaboration is ...06 October 2016
As reported here, earlier this month the U.S. Drug Enforcement Administration (DEA) issued a decision declining to transfer marijuana out of Schedule I. As marijuana remains a Schedule I...07 September 2016